(Q39588969)

13 September 2017

title

FOXO3a nuclear localisation is associated with good prognosis in luminal-like breast cancer (English)

1 reference

13 September 2017

1 reference

Mohammed A Aleskandarany

Mohammed Aleskandarany

3

0 references

Emad A. Rakha

Emad A Rakha

2

0 references

Andrew Green

Andrew R Green

5

0 references

Ian Ellis

Ian O Ellis

6

0 references

author name string

Hany Onsy Habashy

1

1 reference

13 September 2017

Mohamed Ah Ahmed

4

1 reference

13 September 2017

Desmond G Powe

7

1 reference

13 September 2017

language of work or name

English

0 references

publication date

19 February 2011

1 reference

Breast Cancer Research and Treatment

13 September 2017

published in

1 reference

13 September 2017

volume

129

1 reference

13 September 2017

issue

1

1 reference

13 September 2017

page(s)

11-21

1 reference

https://scigraph.springernature.com/pub.10.1007/s10549-010-1161-z

13 September 2017

exact match

0 references

cites work

Steroid receptors in human breast tumorigenesis and breast cancer progression

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1161-Z

A new fork for clinical application: targeting forkhead transcription factors in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1161-Z

Crystal structure of the human FOXO3a-DBD/DNA complex suggests the effects of post-translational modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1161-Z

Forkhead box transcription factor FOXO3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1161-Z

Forkhead box transcription factor FOXO3a regulates estrogen receptor alpha expression and is repressed by the Her-2/neu/phosphatidylinositol 3-kinase/Akt signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1161-Z

Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1161-Z

PI3K/Akt signalling pathway and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1161-Z

Dynamic FoxO transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1161-Z

ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1161-Z

Decisions on life and death: FOXO Forkhead transcription factors are in command when PKB/Akt is off duty

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1161-Z

Cell cycle and death control: long live Forkheads

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1161-Z

Forkhead transcription factors contribute to execution of the mitotic programme in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1161-Z

IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1161-Z

FoxOs at the crossroads of cellular metabolism, differentiation, and transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1161-Z

The forkhead transcription factor FoxO regulates transcription of p27Kip1 and Bim in response to IL-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1161-Z

Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1161-Z

Foxo3a is essential for maintenance of the hematopoietic stem cell pool.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1161-Z

FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1161-Z

Regulation of transactivation-independent proapoptotic activity of p53 by FOXO3a

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1161-Z

The emerging roles of forkhead box (Fox) proteins in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1161-Z

The transcription factor FOXO3a is a crucial cellular target of gefitinib (Iressa) in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1161-Z

FoxO3a transcriptional regulation of Bim controls apoptosis in paclitaxel-treated breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1161-Z

Paclitaxel-induced nuclear translocation of FOXO3a in breast cancer cells is mediated by c-Jun NH2-terminal kinase and Akt.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1161-Z

High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1161-Z

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1161-Z

Forkhead-box A1 (FOXA1) expression in breast cancer and its prognostic significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1161-Z

Expression of luminal and basal cytokeratins in human breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1161-Z

Invasive lobular carcinoma of the breast: response to hormonal therapy and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1161-Z

The prognostic significance of PELP1 expression in invasive breast cancer with emphasis on the ER-positive luminal-like subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1161-Z

PIK3CA expression in invasive breast cancer: a biomarker of poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1161-Z

REporting recommendations for tumor MARKer prognostic studies (REMARK).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1161-Z

Molecular analysis of hormone receptor positive (luminal) breast cancers: what have we learnt?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1161-Z

Progesterone Receptor Status Significantly Improves Outcome Prediction Over Estrogen Receptor Status Alone for Adjuvant Endocrine Therapy in Two Large Breast Cancer Databases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1161-Z

Forkhead box A1 expression in breast cancer is associated with luminal subtype and good prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1161-Z

Induction of Mxi1-SR alpha by FOXO3a contributes to repression of Myc-dependent gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1161-Z

10.1007/S10549-010-1161-Z

21 January 2018

Identifiers

DOI

1 reference

13 September 2017

1 reference